Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer
Clinical trial NCT06180733 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06180733
- Sponsor
- University Medical Center Groningen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2027-12-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.